G Medical Innovations Holdings Ltd. Warrants
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.9
- Today's High:
- $6.9
- Open Price:
- $6.9
- 52W Low:
- $0.126
- 52W High:
- $9
- Prev. Close:
- $7.04
- Volume:
- 318
Company Statistics
- Market Cap.:
- $0
- Book Value:
- -0.444
- Revenue TTM:
- $4.36 million
- Operating Margin TTM:
- -637.71%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -126.31%
- Return on Equity TTM:
- -865.21%
Company Profile
G Medical Innovations Holdings Ltd. Warrants had its IPO on 2021-06-25 under the ticker symbol GMVDW.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. G Medical Innovations Holdings Ltd. Warrants has a staff strength of 0 employees.
Stock update
Shares of G Medical Innovations Holdings Ltd. Warrants opened at $6.9 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $6.9 - $6.9, and closed at $6.9.
This is a -1.99% slip from the previous day's closing price.
A total volume of 318 shares were traded at the close of the day’s session.
In the last one week, shares of G Medical Innovations Holdings Ltd. Warrants have increased by +94.92%.
G Medical Innovations Holdings Ltd. Warrants's Key Ratios
G Medical Innovations Holdings Ltd. Warrants has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months G Medical Innovations Holdings Ltd. Warrants’s revenue was $4.36 million with a gross profit of $0 and an EBITDA of $-26820000. The EBITDA ratio measures G Medical Innovations Holdings Ltd. Warrants's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, G Medical Innovations Holdings Ltd. Warrants’s operating margin was -637.71% while its return on assets stood at -126.31% with a return of equity of -865.21%.
In Q4, G Medical Innovations Holdings Ltd. Warrants’s quarterly earnings growth was a positive 0% while revenue growth was a negative 24%.
G Medical Innovations Holdings Ltd. Warrants’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into G Medical Innovations Holdings Ltd. Warrants’s profitability.
G Medical Innovations Holdings Ltd. Warrants stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
G Medical Innovations Holdings Ltd. Warrants stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $4.83 million
- Total Liabilities
- $9.11 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $550000
- Dividend Payout Ratio
- 0%
G Medical Innovations Holdings Ltd. Warrants ended 2024 with $4.83 million in total assets and $0 in total liabilities. Its intangible assets were valued at $4.83 million while shareholder equity stood at $-7353000.00.
G Medical Innovations Holdings Ltd. Warrants ended 2024 with $0 in deferred long-term liabilities, $9.11 million in other current liabilities, 4835000.00 in common stock, $-115263000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $295000.00 and cash and short-term investments were $295000.00. The company’s total short-term debt was $1,809,000 while long-term debt stood at $0.
G Medical Innovations Holdings Ltd. Warrants’s total current assets stands at $1.99 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $944000.00 compared to accounts payable of $4.66 million and inventory worth $292000.00.
In 2024, G Medical Innovations Holdings Ltd. Warrants's operating cash flow was $0 while its capital expenditure stood at $550000.
Comparatively, G Medical Innovations Holdings Ltd. Warrants paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $6.9
- 52-Week High
- $9
- 52-Week Low
- $0.126
- Analyst Target Price
- $
G Medical Innovations Holdings Ltd. Warrants stock is currently trading at $6.9 per share. It touched a 52-week high of $9 and a 52-week low of $9. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $3.36 and 200-day moving average was $2 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About G Medical Innovations Holdings Ltd. Warrants
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.